Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

Mostrar otras versiones (1)

The individual-level effectiveness of vaccines against clinical disease caused by SARS-CoV-2 is well-established. However, few studies have directly examined the effect of COVID-19 vaccines on transmission. We quantified the effectiveness of vaccination with BNT162b2 (Pfizer-BioNTech mRNA-based vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Prunas, Ottavia, Warren, Joshua L., Crawford, Forrest W., Gazit, Sivan, Patalon, Tal, Weinberger, Daniel M., Pitzer, Virginia E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722617/
https://www.ncbi.nlm.nih.gov/pubmed/34981074
http://dx.doi.org/10.1101/2021.07.13.21260393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722617/
https://www.ncbi.nlm.nih.gov/pubmed/34981074
http://dx.doi.org/10.1101/2021.07.13.21260393

Ejemplares similares